EDGAR Filing Documents for 0001144204-17-000938

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001144204-17-000938

Filing Date

2017-01-05

Accepted

2017-01-05 21:00:16

Documents

Period of Report

2017-01-03

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	v456333_4.html	4
1	OWNERSHIP DOCUMENT	v456333_4.xml	4	3583
	Complete submission text file	0001144204-17-000938.txt		4992

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011

Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH ST., STE. 505 NEW YORK NY 10011

Business Address

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 17512693